CVAC up 10% > CureVac shares are trading higher after the company announced it is in advanced discussions with the European Commission to supply up to 405 million doses of potential mRNA-based COVID-19 vaccines.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.